Journals / Türk Psikiyatri Dergisi / 2006 / Cilt: 17 - Sayı: 1

A case of tianeptine abuse

Tiyaneptin kötüye kullanımı: Bir olgu sunumu

Pages
72–75
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We concluded that the effect of tianeptine and its addiction risk at the patient who had a history of addiction to multiple substances, and spontaneously increased dose of tianeptine during the last one year up to 3000 mg per day at present.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tianeptine is an antidepressant agent like the selective serotonin reuptake inhibitors (SSRIs).
📊
Key Findings & Data:In this article, we report a 24-year-old patient who abused tianeptine for one year.
💡
Conclusion & Impact:We concluded that the effect of tianeptine and its addiction risk at the patient who had a history of addiction to multiple substances, and spontaneously increased dose of tianeptine during the last one year up to 3000 mg per day at present.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Madde bağımlılığı bozuklukları · Erişkin · Erkek

Abstract

Tianeptine is an antidepressant agent like the selective serotonin reuptake inhibitors (SSRIs). The anxiolytic efficacy of tianeptine is similar to that of tricyclic and tetracyclic antidepressants. Very few cases have been reported in connection with excessive consumption of tianeptine. Although it is not reconciled with results of many studies on excessive consumption of tianeptine, stimulant action has been specifically emphasized on some case reports of tianeptine abuse. These reports indicate that a tolerance is developed, there is a strong mode of feeling, and there are physical withdrawal symptoms if not taken again. Treatment with tianeptine can pose a risk for addicted patients in terms of high doses as well as tolerability. In this article, we report a 24-year-old patient who abused tianeptine for one year. The biological tolerance was excellent, and hepatic parameters were not affected. The patient experienced and seeks a psychostimulant effect. The patient had a previous history of addiction to cannabis, opiates and cocaine. We concluded that the effect of tianeptine and its addiction risk at the patient who had a history of addiction to multiple substances, and spontaneously increased dose of tianeptine during the last one year up to 3000 mg per day at present. In the literature, reports of addictions to antidepressants are scarce and most of them involve agents with amphetamine-like properties, including amineptine and tranylcypromine. Other reports involving other antidepressant agents, including amitriptyline, fluoxetine and tianeptine remain exceptional.

Özet

Tiyaneptin, serotonin geri alım engelleyicilerine (SSRI) benzer etki potansiyeline sahip, antidepresan bir ajandır. Anksiyolitik etki profili açısından trisiklik ve tetrasikliklere benzerlik göstermektedir. Kognitif yönden tiyaneptinin dikkati ve öğrenmeyi artırdığı belirtilmektedir. Tiyaneptinin aşırı miktarda alınması konusunda çok az vaka bildirilmiştir. Yüksek doz tiyaneptin kullanımı ile ilgili yapılan birçok çalışmanın sonuçlarına uymamakla birlikte tiyaneptin, kötüye kullanımı ile ilgili olgu sunumlarında özellikle uyarıcı etki vurgulanmıştır. Bazı olgu sunumlarında tiyaneptine tolerans geliştiği, güçlü hissetme hali olduğu ve yeniden alınmaması durumunda fiziksel yoksunluk işaretlerinin görüldüğü belirtilmiştir. Tiyaneptin tedavisi, yüksek doz kullanma ve tolerabilite yönünden bağımlı hastalarda risk oluşturabilmektedir. Bu makalede 24 yaşında geçmişte eroin, esrar ve kokain kullanmış olan, bir yıldan beri bu maddeleri kullanmayarak sadece artan dozda tiyaneptin almaya başlayan bir olgu sunulmuştur. Tiyaneptinin uyarıcı etkisinin olduğunu belirten ve bir yıl içerisinde tiyaneptin dozunu artırarak günde 3000 mg kullanmaya başlayan ve çoğul madde bağımlılığı bulunan hastada tiyaneptinin etkisi, kötüye kullanımı ve bağımlılık riski tartışılmıştır.

🔖

Cite This Article

SAATÇİOĞLU, Ö., ERİM, B. R., ÇAKMAK, D. (2006). A case of tianeptine abuse. Türk Psikiyatri Dergisi, Cilt: 17 - Sayı: 1, 72–75. https://ajindex.com/articles/91976

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ansseau M, Wauthy J, von Freckell R ve ark. (1992) Gradually increased doses of tianeptine: maximal tolerated dose and linearity of the pharmacokinetics. Ann Psiquiatria, 8(suppl.1):56. Czeh B, Michaelis T, Watanabe T ve ark. (2001) Stress-induced changes in cerebral metabolites, hippocampal volume and cell proliferation are prevented by antidepressant treatment with tianeptine. PNAS, 98:12796-12801.
  2. Delalleau B, Dulcire C, Le Moine P, Kamoun A (1988) Analysis of side effects of tianeptine. Clin Neuropharmacol, 11(suppl.2):83-89.
  3. Favre JD, Guelfi-Sozzi, Delalleau B, Loo H (1997) Tianeptine and alcohol dependence. Eur Neuropsychopharmacol, 7(suppl): 347-351.
  4. Guillem E, Lepine JP (2003) Does addiction to antidepressants exist? About a case of one addiction to tianeptine. Encephale, 29(5):456-459.
  5. Invernizzi R, Pozzi L, Garattini S ve ark. (1992) Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism. Neuropharmacology, 31:221-227.
  6. Kasper S, Olie JP (2002) A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression. Eur Psychiatry, 17(suppl 3):331-340.
  7. Labrid C, Mocaer E, Kamoun A (1992) Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. Br J Psychiatry, 160(Suppl 15 ):56-60.
  8. Leterme L, Singlan YS, Auclair V ve ark. (2003) Misuse of tianeptine: five cases of abuse. Ann Med In, 154 Spec No 2:S58-63. Louilot A, Mocaer E, Simon H ve ark. (1990) Difference in the effects of the antidepressant tianeptine on dopaminergic metabolism in the prefrontal cortex and the nucleus accumbens of the rat. A voltametric study. Life Sci, 47(13):1083-1089.
  9. Malka R, Loo H, Ganry H ve ark. (1992) Long-term administration tianeptine in depressed patients after alcohol withdrawal. Br J Psychiatry, 160(suppl.15):66-71.
  10. Mennini T, Mocaer E, Garattini S (1988) Tianeptine and amitryptyline controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology, 19:79-85.
  11. Sacchetti G, Bonini I, Waeterloos GC ve ark. (1993) Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex. Eur J Pharmacol, 236:171-5
  12. Vandel P, Regina W, Bonin B ve ark. (1999) Abuse of tianeptin. A case report. Encephale, 25(6):672-673.
  13. Wagstaff AJ, Ormrod D, Spencer CM (2001) Tianeptine. A review of its use in depressive disorders. CNS Drugs. Adis Drug Evaluation, 15(3):231-259.
  14. Wilde MI, Benfield P (199